Total Payments
$426,309
2024 Payments
$125,017
Companies
52
Transactions
1,232
Medicare Patients
6,212
Medicare Billing
$872,235
Payment Breakdown by Category
Other$380,287 (89.2%)
Food & Beverage$33,517 (7.9%)
Travel$8,125 (1.9%)
Consulting$3,825 (0.9%)
Education$555.68 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $380,287 | 203 | 89.2% |
| Food and Beverage | $33,517 | 982 | 7.9% |
| Travel and Lodging | $8,125 | 28 | 1.9% |
| Consulting Fee | $3,825 | 5 | 0.9% |
| Education | $555.68 | 14 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $204,834 | 347 | $0 (2024) |
| GlaxoSmithKline, LLC. | $115,082 | 151 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $28,365 | 41 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $25,685 | 57 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21,107 | 114 | $0 (2024) |
| Gilead Sciences, Inc. | $18,591 | 30 | $0 (2019) |
| Genentech USA, Inc. | $2,095 | 69 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $1,233 | 46 | $0 (2024) |
| GENZYME CORPORATION | $1,138 | 42 | $0 (2024) |
| Insmed, Inc. | $921.06 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125,017 | 232 | AstraZeneca Pharmaceuticals LP ($90,313) |
| 2023 | $112,787 | 237 | AstraZeneca Pharmaceuticals LP ($52,674) |
| 2022 | $50,610 | 162 | AstraZeneca Pharmaceuticals LP ($25,654) |
| 2021 | $33,650 | 112 | GlaxoSmithKline, LLC. ($19,005) |
| 2020 | $20,167 | 107 | GlaxoSmithKline, LLC. ($7,458) |
| 2019 | $16,144 | 138 | AstraZeneca Pharmaceuticals LP ($6,500) |
| 2018 | $27,529 | 113 | Boehringer Ingelheim Pharmaceuticals, Inc. ($7,567) |
| 2017 | $40,406 | 131 | Bayer HealthCare Pharmaceuticals Inc. ($17,835) |
All Payment Transactions
1,232 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,530.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,530.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/06/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $32.51 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Respiratory | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.61 | General |
| Category: Immunology | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Neurology | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $30.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $121.25 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,598 | 5,193 | $596,100 | $225,231 |
| 2022 | 22 | 1,993 | 6,547 | $736,622 | $278,071 |
| 2021 | 22 | 1,661 | 7,878 | $611,765 | $238,032 |
| 2020 | 16 | 960 | 1,749 | $396,155 | $130,901 |
Total Patients
6,212
Total Services
21,367
Medicare Billing
$872,235
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 272 | 1,057 | $248,395 | $112,549 | 45.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 43 | 285 | $57,000 | $29,409 | 51.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 46 | 62 | $21,700 | $9,170 | 42.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 139 | 170 | $32,694 | $8,526 | 26.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 118 | $17,700 | $8,098 | 45.8% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 35 | 2,078 | $20,780 | $7,895 | 38.0% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 145 | 181 | $45,250 | $6,950 | 15.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 145 | 183 | $33,914 | $6,148 | 18.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 41 | 41 | $11,275 | $5,803 | 51.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 38 | 53 | $11,925 | $5,296 | 44.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $13,797 | $5,153 | 37.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 73 | 76 | $9,524 | $5,099 | 53.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 59 | $10,325 | $4,544 | 44.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 114 | 217 | $21,700 | $2,713 | 12.5% |
| 94200 | Test to measure largest amount of air breathed in an out | Office | 2023 | 143 | 179 | $8,950 | $2,435 | 27.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 41 | 124 | $12,400 | $1,528 | 12.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 41 | 41 | $4,075 | $1,475 | 36.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 59 | 86 | $1,290 | $722.40 | 56.0% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 28 | 28 | $3,509 | $613.20 | 17.5% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 18 | 18 | $900.00 | $368.28 | 40.9% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 12 | 14 | $773.22 | $228.62 | 29.6% |
| 93225 | Electrocardiogram (ecg) 2-day continuous | Office | 2023 | 13 | 13 | $1,303 | $205.20 | 15.7% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 13 | 13 | $680.68 | $183.24 | 26.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 11 | 12 | $360.00 | $62.50 | 17.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 23 | 49 | $5,880 | $54.74 | 0.9% |
About Dr. Ali El Atat, M.D
Dr. Ali El Atat, M.D is a Internal Medicine healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1487853008.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ali El Atat, M.D has received a total of $426,309 in payments from pharmaceutical and medical device companies, with $125,017 received in 2024. These payments were reported across 1,232 transactions from 52 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($380,287).
As a Medicare-enrolled provider, El Atat has provided services to 6,212 Medicare beneficiaries, totaling 21,367 services with total Medicare billing of $872,235. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Sleep Medicine
- Location Brooklyn, NY
- Active Since 07/13/2007
- Last Updated 08/06/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487853008
Products in Payments
- FASENRA (Biological) $100,188
- BREZTRI (Drug) $49,200
- TRELEGY ELLIPTA (Drug) $37,509
- AIRSUPRA (Drug) $30,105
- Adempas (Drug) $28,365
- DUPIXENT (Biological) $26,751
- AREXVY (Drug) $25,317
- BEVESPI AEROSPHERE (Drug) $11,994
- SPIRIVA RESPIMAT (Drug) $9,684
- FASENRA (Drug) $8,142
- Letairis (Drug) $7,496
- BREZTRI AEROSPHERE (Drug) $4,037
- Xolair (Biological) $2,000
- ANORO ELLIPTA (Drug) $1,200
- Arikayce (Drug) $878.50
- OPSUMIT (Drug) $814.79
- OFEV (Drug) $779.33
- ELIQUIS (Drug) $771.32
- NUCALA (Biological) $746.55
- TEZSPIRE (Biological) $739.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Brooklyn
Bruce Berger, M.d, M.D
Internal Medicine — Payments: $3.0M
Internal Medicine $3.0M
Dr. Jesi Ramone, Md, MD
Internal Medicine — Payments: $701,491
Internal Medicine $701,491
Manish Parikh, Md, MD
Internal Medicine — Payments: $360,332
Internal Medicine $360,332
Dr. Samuel Uter, Md, MD
Internal Medicine — Payments: $238,375
Internal Medicine $238,375
Dr. Bharath Reddy, Md, MD
Internal Medicine — Payments: $159,733
Internal Medicine $159,733
Sima Muster
Internal Medicine — Payments: $137,530
Internal Medicine $137,530